Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) Equity Average (2016 - 2025)

Jaguar Health (JAGX) has disclosed Equity Average for 11 consecutive years, with $5.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Equity Average fell 62.13% to $5.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.6 million, a 62.13% decrease, with the full-year FY2024 number at $5.7 million, up 221.96% from a year prior.
  • Equity Average was $5.6 million for Q3 2025 at Jaguar Health, up from $3.9 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $31.8 million in Q2 2021 to a low of $1.1 million in Q4 2022.
  • A 5-year average of $10.3 million and a median of $6.7 million in 2023 define the central range for Equity Average.
  • Peak YoY movement for Equity Average: surged 718.77% in 2021, then plummeted 93.29% in 2022.
  • Jaguar Health's Equity Average stood at $16.7 million in 2021, then tumbled by 93.29% to $1.1 million in 2022, then soared by 181.83% to $3.2 million in 2023, then skyrocketed by 210.33% to $9.8 million in 2024, then plummeted by 42.63% to $5.6 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Equity Average are $5.6 million (Q3 2025), $3.9 million (Q2 2025), and $3.7 million (Q1 2025).